Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?

about

Changing treatment paradigms for the management of inflammatory bowel disease.

P2860

Q48537463-50C22288-5866-458B-B128-444C8F7A08A7

P2860

Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?

Item

http://www.wikidata.org/entity/Q42332335

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Is the Therapeutic Drug Monito ...... matory Bowel Disease Patients?

@en

Is the Therapeutic Drug Monito ...... matory Bowel Disease Patients?

@nl

type

Item

label

Is the Therapeutic Drug Monito ...... matory Bowel Disease Patients?

@en

Is the Therapeutic Drug Monito ...... matory Bowel Disease Patients?

@nl

prefLabel

Is the Therapeutic Drug Monito ...... matory Bowel Disease Patients?

@en

Is the Therapeutic Drug Monito ...... matory Bowel Disease Patients?

@nl

P1476

Is the Therapeutic Drug Monito ...... matory Bowel Disease Patients?

@en

P2093

Chang Soo Eun

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)

Characteristics of Pediatric Inflammatory Bowel Disease in Korea: Comparison with EUROKIDS Data.

Expression of TIM-3, Human β-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy

Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease

Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review.

Optimizing anti-TNF treatments in inflammatory bowel disease.

Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease.

Tailoring anti-TNF therapy in IBD: drug levels and disease activity.

Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases.

P304

3-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.5009/GNL16574

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28053295

http://www.w3.org/2001/XMLSchema#string

P921

TNF inhibitor

P932

5221852

http://www.w3.org/2001/XMLSchema#string

Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?

about

P2860

P2860

Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932